Researchers have made a correction to a recent study published in the journal Nature, which explored the potential of covalent targeted radioligands to potentiate radionuclide therapy. The correction was made to ensure the accuracy and reliability of the findings.

According to the correction, errors were discovered in the original article, which was published on May 22, 2024. In Fig. 1e, the labels were incorrectly listed as EDG instead of EWG, and in Fig. 3b, the labels were incorrectly listed as mFS instead of pFS. The errors have been corrected in both the HTML and PDF versions of the article, as well as in the Supplementary Information.

The correction also notes that during the editing process, the authors inadvertently copied images of LNCaP tumours into the panel of Supplementary Fig. 31, where images of 22Rv1 tumours were intended to be displayed. Fortunately, the editors were able to recover the original 22Rv1 tumour images from prior versions of the manuscript and have reinstated them in the corrected Supplementary Fig. 31.

Xi-Yang Cui, one of the authors of the study, acknowledged the mistake and expressed gratitude for the editors' diligence in ensuring the accuracy of the research. "We appreciate the editors' attention to detail and commitment to maintaining the integrity of our research," Cui said.

The study itself focused on the potential of covalent targeted radioligands to enhance the effectiveness of radionuclide therapy, a treatment approach that uses radioactive isotopes to target and destroy cancer cells. The research has significant implications for the development of new cancer treatments and highlights the importance of continued research in this area.

The correction to the study serves as a reminder of the importance of accuracy and attention to detail in scientific research. It also underscores the commitment of researchers and editors to ensuring the integrity and reliability of scientific findings.

As the research continues to evolve, scientists and researchers will continue to build upon the findings of this study and explore new avenues for the development of effective cancer treatments.